InflaRx Spotlights Izicopan HS Data, Phase 2b Plans and 30% Cost Cuts at Guggenheim Summit
Original source ↗  |  February 14, 2026 at 03:02 UTC  |  Finnhub - AMGN

No analysis available.

Trade Ideas
Ticker Direction Speaker Thesis Time
LONG Finnhub News InflaRx highlighted positive Izicopan HS data, outlined Phase 2b plans, and announced significant cost reductions at a summit.